JW Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
JW Asset Management's CPRX Position: Q3 2026 in Review
JW Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 388,392 shares — an estimated $12.2M sold.
JW Asset Management first reported a position in CPRX in Q4 2022 and held it in 15 quarters. The position peaked at $12.2M in Q2 2026. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- JW Asset Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- JW Asset Management sold 388,392 Catalyst Pharmaceutical shares in Q3 2026, an estimated $12.2M.
- JW Asset Management first reported a position in Catalyst Pharmaceutical in Q4 2022 and held it in 15 quarters.
- JW Asset Management's Catalyst Pharmaceutical position peaked at $12.2M in Q2 2026.
- 3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on JW Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.